- Home
- IXHL vs PASG Comparison
IXHL vs PASG Comparison
Compare IXHL & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- PASG
- Stock Information
- Founded
- IXHL 2001
- PASG 2017
- Country
- IXHL Australia
- PASG United States
- Employees
- IXHL N/A
- PASG N/A
- Industry
- IXHL
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- IXHL
- PASG Health Care
- Exchange
- IXHL Nasdaq
- PASG Nasdaq
- Market Cap
- IXHL 39.2M
- PASG 42.2M
- IPO Year
- IXHL N/A
- PASG 2020
- Fundamental
- Price
- IXHL $2.00
- PASG $0.52
- Analyst Decision
- IXHL
- PASG Strong Buy
- Analyst Count
- IXHL 0
- PASG 1
- Target Price
- IXHL N/A
- PASG $13.00
- AVG Volume (30 Days)
- IXHL 43.4K
- PASG 229.5K
- Earning Date
- IXHL 09-30-2024
- PASG 11-13-2024
- Dividend Yield
- IXHL N/A
- PASG N/A
- EPS Growth
- IXHL N/A
- PASG N/A
- EPS
- IXHL N/A
- PASG N/A
- Revenue
- IXHL $86,000.00
- PASG N/A
- Revenue This Year
- IXHL N/A
- PASG N/A
- Revenue Next Year
- IXHL N/A
- PASG N/A
- P/E Ratio
- IXHL N/A
- PASG N/A
- Revenue Growth
- IXHL N/A
- PASG N/A
- 52 Week Low
- IXHL $0.80
- PASG $0.49
- 52 Week High
- IXHL $12.68
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- IXHL 41.84
- PASG 37.27
- Support Level
- IXHL $2.22
- PASG $0.58
- Resistance Level
- IXHL $3.12
- PASG $0.68
- Average True Range (ATR)
- IXHL 0.28
- PASG 0.06
- MACD
- IXHL -0.04
- PASG -0.01
- Stochastic Oscillator
- IXHL 0.00
- PASG 13.44
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.